Triple

T5114927
Position Surface form Disambiguated ID Type / Status
Subject Memantine E115307 entity
Predicate isMarketedUnderBrandName P40804 FINISHED
Object Namenda
Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
E494105 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Namenda | Statement: [Memantine, isMarketedUnderBrandName, Namenda]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Namenda
Context triple: [Memantine, isMarketedUnderBrandName, Namenda]
  • A. Donepezil
    Donepezil is a cholinesterase inhibitor medication primarily used to treat cognitive symptoms of Alzheimer's disease.
  • B. Toclafane
    The Toclafane are a race of deadly, cybernetic spheres revealed to be the future remnants of humanity in the Doctor Who universe, serving as instruments of mass destruction under the Master.
  • C. rivastigmine
    Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
  • D. riluzole
    Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).
  • E. amantadine
    Amantadine is an antiviral and antiparkinsonian medication used to help manage motor symptoms such as tremor and rigidity in people with Parkinson’s disease.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Namenda
Triple: [Memantine, isMarketedUnderBrandName, Namenda]
Generated description
Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Namenda
Target entity description: Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • A. Donepezil
    Donepezil is a cholinesterase inhibitor medication primarily used to treat cognitive symptoms of Alzheimer's disease.
  • B. Toclafane
    The Toclafane are a race of deadly, cybernetic spheres revealed to be the future remnants of humanity in the Doctor Who universe, serving as instruments of mass destruction under the Master.
  • C. rivastigmine
    Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
  • D. riluzole
    Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).
  • E. amantadine
    Amantadine is an antiviral and antiparkinsonian medication used to help manage motor symptoms such as tremor and rigidity in people with Parkinson’s disease.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: isMarketedUnderBrandName
Context triple: [Memantine, isMarketedUnderBrandName, Namenda]
  • A. hasBrandName chosen
    Indicates that an entity is associated with or identified by a specific brand name.
  • B. originalMarketingName
    Indicates the original marketing or brand name under which an entity (such as a product or service) was first promoted or sold.
  • C. hasUnderlyingCompanyBrand
    Indicates that one entity is associated with or operates under the corporate brand of another company as its underlying brand.
  • D. hasMarketingCategory
    Indicates that an entity is associated with a specific marketing category or segment used for classification or targeting.
  • E. usedBrand
    Indicates that an entity has utilized, applied, or operated a particular brand in some context.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd4441d1648190a54a533895041987 completed March 20, 2026, 12:57 p.m.
NER Named-entity recognition batch_69bd75ce6044819094166aebf0688665 completed March 20, 2026, 4:29 p.m.
NED1 Entity disambiguation (via context triple) batch_69bebaadfaac8190aa0407196e5c4c20 completed March 21, 2026, 3:35 p.m.
NEDg Description generation batch_69bebb1a4370819085bcbe73a0b8c68e completed March 21, 2026, 3:36 p.m.
NED2 Entity disambiguation (via description) batch_69bebcf63784819097be14bb7dcbf4d9 completed March 21, 2026, 3:44 p.m.
PD Predicate disambiguation batch_69bd715fe3a8819087d3065adddba515 completed March 20, 2026, 4:10 p.m.
Created at: March 20, 2026, 1:41 p.m.